FDAsafety guidance66% confidence
Report on the State of Pharmaceutical Quality
Source: FDA
Why This Matters
Why this matters: provides agency context on safety guidance that may shape timing or evidence expectations for Biocon Pharma; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
The mission of the Office of Pharmaceutical Quality is to assure that quality medicines are available to the American public. The annual Report on the State of Pharmaceutical Quality is intended to help characterize the quality of the U.S. drug supply chain. Learn more.
Supporting Context
- Therapeutic area
- Oncology · Small Molecule
- Sub-indication
- General
Related signal: FDA Accepts Supplement for Lenalidomide by Biocon Pharma